Close Menu

marketing agreement

Under the terms of the agreement, Sciex has exclusive reseller and marketing rights to the XCMSplus software.

The partners will jointly promote the BD FACS single-cell sorting instrument alongside Cellular Research's molecular bar-coding technology, Precise.

LifeMap will promote Toldot's products to academic researchers, research hospitals, and biopharmaceutical firms.

PerkinElmer's liquid and gas chromatography portfolio will be standardized on Waters' Empower Software.

NEW YORK (GenomeWeb) – Rosetta Genomics today announced a deal to sell tests from Admera Health to oncologists and pathologists.

NEW YORK (GenomeWeb) – VHLGenetics today announced an agreement with Labocor to market VHLGenetics' products in Spain.

NEW YORK (GenomeWeb) – SomaLogic and NEC today announced an exclusive deal granting NEC exclusive marketing rights to the Somascan assay in Japan.

NEW YORK (GenomeWeb) – Lucigen announced yesterday that it has partnered with Thermo Fisher Scientific to develop and launch a long mate pair library kit for the Ion Torrent Personal Genome Machine sequencing platform.

NEW YORK (GenomeWeb) — ATCC has partnered with the US Centers for Disease Control and Prevention and Thermo Fisher Scientific to bring a rapid, cost-effective PCR-based method of monitoring HIV drug resistance to resource-limited countries, ATCC said today.

NEW YORK (GenomeWeb) – Cancer Genetics today said that it has signed a multi-year agreement with PathAdvantage Associated to offer its FHACT test, a FISH-based genomic test for detecting and managing cervical cancer, and to collaborate on research in support of the test.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.